罕见:心脏纤维瘤1例

2021-05-11 网络 网络

心脏纤维瘤是主要发生于婴幼儿的罕见的良性肿瘤,是该年龄段第二好发的肿瘤,仅次于横纹肌瘤。现结合印第安纳大学影像中心的 Tyler Fredenburg 医生在 auntminnie 上发布的病例来对该

心脏纤维瘤是主要发生于婴幼儿的罕见的良性肿瘤,是该年龄段第二好发的肿瘤,仅次于横纹肌瘤。现结合印第安纳大学影像中心的 Tyler Fredenburg 医生在 auntminnie 上发布的病例来对该病进行介绍。 病史 女婴,昏迷病史。 影像学检查 图 1 胸片示心脏增大 图 2 为冠状位 CT 图 3 为 T2 横断压脂序列 图 4 为 T1 横断压脂序列 影像学发现 胸片发现心脏中度增大,左心室边缘局限性突出。 CT 示一边界清楚的实性肿块,直径约 5 cm,起源于左室侧后部游离壁。肿块中央见散在游离钙化灶。肿块呈低密度,CT 值约 30 到 40 Hu 。临近的心肌 CT 值约 90 Hu,骨骼肌 CT 值约 50 Hu。心包内有少量渗出。心脏 MRI 示直径 5cm 信号均匀的肿块,累及左心室侧后游离壁,未累及二尖瓣和左心室流出道。肿块向心尖延伸,并贴近室间隔。 诊断:心脏纤维瘤 鉴别诊断:在胎儿时,需要鉴别纤维瘤和横纹肌瘤。如果肿块为多发或有结节样坏死,即可确诊为横纹肌瘤。相反的,如果肿瘤是心室内实性的且有钙化,则可以诊断为纤维瘤。横纹肌肉瘤是一种罕见肿瘤,无钙化,每个房室内

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1387758, encodeId=0fca138e758d3, content=<a href='/topic/show?id=f210e72532e' target=_blank style='color:#2F92EE;'>#纤维瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77253, encryptionId=f210e72532e, topicName=纤维瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fc62500009, createdName=12498474m30暂无昵称, createdTime=Thu May 13 11:02:46 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467611, encodeId=c0d0146e611a2, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Thu May 13 11:02:46 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964771, encodeId=1b34964e71e9, content=科技发展,攻克更多难题, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/9612b32e383b42ae9682a63fcff2070e/ecec6a435c00484c830415664fdbb048.jpg, createdBy=88c54874945, createdName=吴生, createdTime=Wed May 12 00:45:43 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1387758, encodeId=0fca138e758d3, content=<a href='/topic/show?id=f210e72532e' target=_blank style='color:#2F92EE;'>#纤维瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77253, encryptionId=f210e72532e, topicName=纤维瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fc62500009, createdName=12498474m30暂无昵称, createdTime=Thu May 13 11:02:46 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467611, encodeId=c0d0146e611a2, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Thu May 13 11:02:46 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964771, encodeId=1b34964e71e9, content=科技发展,攻克更多难题, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/9612b32e383b42ae9682a63fcff2070e/ecec6a435c00484c830415664fdbb048.jpg, createdBy=88c54874945, createdName=吴生, createdTime=Wed May 12 00:45:43 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
    2021-05-13 syscxl
  3. [GetPortalCommentsPageByObjectIdResponse(id=1387758, encodeId=0fca138e758d3, content=<a href='/topic/show?id=f210e72532e' target=_blank style='color:#2F92EE;'>#纤维瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77253, encryptionId=f210e72532e, topicName=纤维瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fc62500009, createdName=12498474m30暂无昵称, createdTime=Thu May 13 11:02:46 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467611, encodeId=c0d0146e611a2, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Thu May 13 11:02:46 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964771, encodeId=1b34964e71e9, content=科技发展,攻克更多难题, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/9612b32e383b42ae9682a63fcff2070e/ecec6a435c00484c830415664fdbb048.jpg, createdBy=88c54874945, createdName=吴生, createdTime=Wed May 12 00:45:43 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
    2021-05-12 吴生

    科技发展,攻克更多难题

    0